Spectra Optia
Payments companies reported to CMS as associated with Spectra Optia. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Spectra Optia, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Spectra Optia
These are the largest totals companies reported as associated with Spectra Optia. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ira Davis | Cleveland, OH | Pediatric Nephrology | $47,743.75 |
| Tina Ipe | Little Rock, AR | Clinical Pathology/Laboratory Medicine | $13,800.00 |
| Julie Kanter Washko | Birmingham, AL | Pediatric Hematology-Oncology | $8,504.53 |
| John Manis | Greenbrae, CA | Plastic Surgery | $8,000.00 |
| Robert Maitta | Cleveland, OH | Blood Banking & Transfusion Medicine | $5,435.00 |
| Ilene Ruhoy | Seattle, WA | Neurology With Special Qualifications In Child Neurology | $4,000.00 |
| Melissa Palmer | Plainview, NY | Gastroenterology (Internal Medicine) | $3,300.00 |
| Erin Goodhue | Columbus, OH | Anatomic Pathology & Clinical Pathology | $2,400.00 |
| Deva Sharma | Nashville, TN | Hematology & Oncology | $2,000.00 |
| Asif Alavi | Detroit, MI | Hematology (Internal Medicine) | $1,495.46 |
Prescribed Spectra Optia?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.